MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: Biomaterials/Tissue Engineering/Regenerative Medicine
LifeCell, Inc.-CeMBR-LIFC
Organization & Developments: Lifecell
Parents
LifeCell, Inc.-CeMBR-LIFC
Children
2014: U.S. Navy_WRNMMC: STRATTICE REGENERATIVE TISSUE MATRIX
2017: U.S. Army_AlloDerm Tissue Matrix
2018: U.S. Air Force_LifeCell
AlloDerm® Regenerative Tissue Matrix, the flagship of LifeCell, was developed in 1994 as a graft for burn patients.
AlloDerm® Tissue Matrix allows surgeons to restore many types of tissue damaged through injury or disease using the regenerative power of their patients’ own tissue.
Key Concepts-Lifecell
LifeCell has capitalized on interest in xenograft meshes, and has experienced remarkable growth over 2009
Lifecell's flagship material ("ALLODERM") is produced utilizing proprietary processing techniques
Medical technology company and a pioneer in the field of tissue engineering.
Thus leaving an ideal "scaffold" material for tissue repair, reinforcement, and replacement applications
Versatility of AlloDerm® Tissue Matrix has led to its use in a host of other reconstructive applications, primarily in hernia, abdominal wall repair and breast reconstruction postmastectomy.
Which remove cells and other impurities from allograft dermis
Jumps
*Key People: Lifecell
Finance & Acquisitions: Lifecell